Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bavarian Nordic ADR (OP: BVNRY ) 13.95 +1.80 (+14.81%) Streaming Delayed Price Updated: 3:59 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Bavarian Nordic ADR < Previous 1 2 Next > Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency August 16, 2024 Bavarian Nordic submits data to European Medicines Agency seeking approval to extend Imvanex vaccine use to adolescents. New trials in younger children planned as global demand for smallpox and mpox... Via Benzinga Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On? August 15, 2024 Several healthcare stocks associated with mpox are seeing increased attention Thursday after the World Health Organization declared a public health emergency in response to an mpox outbreak in Africa. Via Benzinga WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak August 14, 2024 A public health emergency for mpox in Africa saw vaccine stocks jump Wednesday. A look at the stocks and what's next for fighting the virus. Via Benzinga Bavarian Nordic Beefs Up Chikungunya Vaccine Race With Valneva With Encouraging Late-Stage Trial Data June 20, 2023 Bavarian Nordic A/S's (OTC: BVNRY) phase 3 chikungunya virus vaccine (CHIKV VLP (PXVX0317) clinical trial has hit its primary endpoint in Via Benzinga International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 16th and 17th, 2023 May 09, 2023 From Virtual Investor Conferences Via GlobeNewswire Deutsche Bank ADR Investor Conference: Presentations Now Available for Online Viewing May 18, 2023 Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com From Virtual Investor Conferences Via GlobeNewswire Monkeypox Vaccine Maker Bavarian Nordic Bets $380M On Emergent Bio's Travel Vaccines February 15, 2023 Via Benzinga Emergent BioSolutions Announces Sale of Travel Health Business to Bavarian Nordic for Up To $380 Million February 15, 2023 From Emergent BioSolutions Via GlobeNewswire Bavarian Nordic Recruits US Firm For Packaging Services For Its Monkeypox Vaccine August 19, 2022 Via Benzinga International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 16th and 17th, 2023 May 15, 2023 From Virtual Investor Conferences Via GlobeNewswire West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies December 15, 2022 Via Benzinga Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa November 03, 2022 Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks. After analyzing 1,463 cases... Via Benzinga White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox September 02, 2022 Via Benzinga Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed August 26, 2022 Via Benzinga SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report August 25, 2022 In an effort to prevent bioterrorism attacks, just in case, SIGA Technologies Inc (NASDAQ: SIGA) started working on the smallpox treatment, Tpoxx, after the 9/11 terrorist attack that shook the world.... Via Benzinga 3 Top Monkeypox Stocks to Buy Right Now August 24, 2022 With cases of a frightening disease spreading to all 50 states, it’s now time to consider the top monkeypox stocks to buy right now. Via InvestorPlace PTON Stock Pops as Peloton Products Launch on Amazon August 24, 2022 Peloton (PTON) stock is getting a boost on Wednesday after the fitness company's products started selling on Amazon (AMZN). Via InvestorPlace BVNRY Stock Alert: What to Know as Bavarian Nordic Signs Supply Agreement August 24, 2022 Bavarian Nordic (BVNRY) stock is on the move Wednesday after the monkeypox vaccine company signed a supply agreement with PAHO. Via InvestorPlace Benzinga Before The Bell: Top Amazon Seller Succumbs To Economic Meltdown, Twitter To Tackle Toxic Content, Spam Bots, Bed Bath & Beyond Secures Loan Deal As It Tries To Stay Afloat And Other Top Financial Stories Wednesday, August 24 August 24, 2022 CNBC Top Amazon Seller Succumbs To Economic Meltdown Via Benzinga Bavarian Nordic Making All Efforts To Stretch Capacity To Boost Monkeypox Vaccine Supplies August 24, 2022 Bavarian Nordic A/S (OTC: BVNRY) said it was making "every effort" to meet the high demand for its monkeypox vaccine worldwide as it kept its business outlook for the year. Via Benzinga Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch August 23, 2022 The only FDA-approved monkeypox vaccine from Bavarian Nordic A/S (OTC: BVNY) is in short supply. Via Benzinga Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test August 19, 2022 Via Benzinga Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment August 18, 2022 Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments. Via Benzinga 7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher August 17, 2022 These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up. Via InvestorPlace The Only Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand August 17, 2022 Bavarian Nordic A/S (OTC: BVNKF), the only company with an approved vaccine for monkeypox, said it’s no longer sure it can meet demand as cases continue to rise worldwide, Via Benzinga Plan To Extend Supply Of Monkeypox Vaccine On Cusp Of Emergency Clearance: Report August 09, 2022 A plan to extend the limited supply of monkeypox vaccine in order to provide additional doses may soon be receiving emergency clearance by U.S. health officials. Via Benzinga 3 Monkeypox Stocks to Buy as Biden Declares Public Health Emergency August 05, 2022 Monkeypox stocks are about to rise now that the White House has declared the virus a public health emergency. Here are the stocks to watch. Via InvestorPlace VRAX Stock Alert: Why Is Virax Biolabs Up 120% Today? August 01, 2022 With monkeypox infections rising, Virax Biolabs’ PCR test for the underlying virus is bolstering sentiment for VRAX stock. Via InvestorPlace Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak August 01, 2022 The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care... Via Benzinga Why Is SIGA Technologies (SIGA) Stock Plunging 23% Today? July 29, 2022 SIGA stock is sinking lower after the FDA released a report, stating that TPOXX has not demonstrated efficacy in humans against monkeypox. Via InvestorPlace < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.